Lipid Metabolic Reprogramming in Hepatocellular Carcinoma

Area of Science:

• Oncology
• Metabolic pathways
• Hepatocellular carcinoma (HCC) research

Background:

• Metabolic reprogramming is a cancer hallmark.
• Fatty acid (FA) metabolism alterations are increasingly recognized in carcinogenesis.
• Obesity and nonalcoholic steatohepatitis (NASH) are significant risk factors for HCC, creating a lipid-rich environment.

Purpose of the Study:

• To review the role of FA metabolism in hepatocarcinogenesis.
• To highlight lipid metabolic reprogramming in obesity- and NASH-driven HCC.
• To discuss recent insights into how HCC cells adapt to and exploit lipid-rich conditions.

Main Methods:

• Literature review of recent studies on FA metabolism and HCC.
• Analysis of mechanisms underlying lipid metabolic reprogramming in hepatocarcinogenesis.
• Focus on findings related to obesity- and NASH-driven HCC.

Main Results:

• Accumulating evidence supports the critical role of lipid metabolic reprogramming in various hepatocarcinogenesis scenarios.
• Specific insights into how HCC cells adapt to lipid-rich conditions driven by obesity and NASH have been obtained.
• FA metabolism pathways are crucial for HCC progression in these specific contexts.

Conclusions:

• Lipid metabolic reprogramming is a key adaptation for cancer cells, particularly in HCC.
• Understanding FA metabolism in obesity- and NASH-driven HCC offers new therapeutic avenues.
• Further research into lipid metabolism is essential for combating liver cancer progression.